000			01821cam a2200181 4500
100	1		_aSCHWARTZ Jonathan
245			_aIs there an authoritarian advantage in pandemic response? _ba comparative case study of China's responses to SARS-CoV-1 (2003) and SARS-CoV-2 (2019)/ _cJonathan Schwartz
260			_c2022
520			_aEffective pandemic response has become an increasingly important focus for research in the face of the COVID-19 pandemic. While there are a number of variables that may be considered as influencing effective response, this paper focuses on the potential impact of an "authoritarian advantage" in achieving an effective response in the period prior to pharmaceutical interventions being available with China as a case study. In essence, this paper explores whether China enjoys an authoritarian advantage, and if so, how it functions. This study compares China's SARS-CoV-1 (2003) response with its SARS-CoV-2 (2019) response by exploring the impact of the authoritarian advantage on the state's ability to effectively engage three key explanatory variables - centralized decision-making powers, public support and media engagement. SARS-CoV-2 is the virus known as severe acute respiratory syndrome coronavirus 2. The disease SARS-CoV-2 causes is COVID-19 (coronavirus disease 2019). SARS-CoV-1 is the virus known as severe acute respiratory syndrome coronavirus 1. It causes SARS (2003).
650			_aCHINA _xCOVID-19 _xHEALTH
650			_aAUTHORITARIAN ADVANTAGE
650			_aPANDEMIC RESPONSE
650			_aEFFECTIVENESS
773			_aIssues and Studies: _gVol 58, No 2, June 2022, pp.2250001-(1) 2250001-(27) (34)
598			_aCHINA, COVID-19, HEALTH
856			_uhttps://www.worldscientific.com/doi/epdf/10.1142/S1013251122500011 _zClick here for full text
945			_i67764.1001 _rY _sY
999			_c41762 _d41762